CELGENE CORPORATION v. SYNTHON PHARMACEUTICALS, INC. et al > Summary
Court Case Number 1:18-cv-00540
Filing Date Jun 21, 2018
Termination Date Jul 25, 2018
Court North Carolina Middle District Court
Status Dismissed - Voluntarily
Plaintiff
Plaintiff Attorneys
6Celgene
Attorney Name: John D. Wooten IV
Womble Bond Dickinson
Celgene
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Celgene
Attorney Name: Anthony M. Insogna
Jones Day
Celgene
Attorney Name: Cary Miller
Jones Day
Defendant Attorneys
4Alvogen
Attorney Name: Joseph P. Hammond
Ellis & Winters LLP
Synthon Pharmaceuticals, Inc.
Attorney Name: Joseph P. Hammond
Ellis & Winters LLP
Syntheon, LLC
Attorney Name: Joseph P. Hammond
Ellis & Winters LLP
Counter Defendant
Celgene
Attorney Name: John D. Wooten IV
Womble Bond Dickinson
Counter Claimant
4Alvogen
Attorney Name: Joseph P. Hammond
Ellis & Winters LLP
Syntheon, LLC
Attorney Name: Joseph P. Hammond
Ellis & Winters LLP
Synthon Pharmaceuticals, Inc.
Attorney Name: Joseph P. Hammond
Ellis & Winters LLP
Synthon Pharmaceuticals, Inc.
Attorney Name: Joseph P. Hammond
Ellis & Winters LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08828427 | Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione | Sep 9, 2014 |
| 08735428 | Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione | May 27, 2014 |
| 08673939 | Methods for treating multiple myeloma with 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione | Mar 18, 2014 |
| 08198262 | Methods for treating multiple myeloma using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione | Jun 12, 2012 |
